Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.

Lyne Gagnon, PhD, Jean Barabe, PhD, Christopher Penney, PhD, Denis-Claude Roy, MD, Vladimir Kovcin, MD, Snezana Bosnjak, MD, Pierre Laurin, MSc

Blood (2007) 110 (11): 2211.

https://doi.org/10.1182/blood.V110.11.2211.2211

Published: 2007

Journal Articles

Oral Administration of PBI-1402 Significantly Reduces Erythropenia and Accelerates Peripheral Blood Recovery in Myeloablated Mice Post Transplantation.

Marie-Josée Morin, Gorazd Krosl, Mouna Lagraoui, Brigitte Grouix, Christopher Penney, Lyne Gagnon, Denis-Claude Roy

Blood (2006) 108 (11): 3201.

https://doi.org/10.1182/blood.V108.11.3201.3201

Published: 2006

Journal Articles

PBI-1402: A Low Molecular Weight Synthetic Hematopoietic Growth Stimulant.

Brigitte Grouix, Nathalie Julien, Mouna Lagraoui, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy, Christopher Penney, Lyne Gagnon

Blood (2006) 108 (11): 4222.

https://doi.org/10.1182/blood.V108.11.4222.4222

Published: 2006

Journal Articles

PBI-1402: A New Candidate for the Treatment of Anemia.

Lyne Gagnon, Jean Barabé, Mouna Lagraoui, Brigitte Grouix, Nathalie Julien, Michel Asselin, Dannyck Gaudreau, François Sarra-Bournet, Boulos Zacharie, Christopher Penney, Pierre Laurin, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy

Blood (2006) 108 (11): 4223.

https://doi.org/10.1182/blood.V108.11.4223.4223

Published: 2006

Journal Articles

PBI-1402: A Non-Toxic Immunorestorative Small Molecule for the Treatment of Anemia.

Mouna Lagraoui, Brigitte Grouix, Nathalie Julien, Michel Asselin, Dannyck Gaudreau, François Sarra-Bournet, Marie-Josée Morin, Gorazd Krosl, Denis-Claude Roy, Christopher Penney, Lyne Gagnon

Blood (2006) 108 (11): 4224.

https://doi.org/10.1182/blood.V108.11.4224.4224

Published: 2006

NARROW

Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.

Oral Administration of PBI-1402 Significantly Reduces Erythropenia and Accelerates Peripheral Blood Recovery in Myeloablated Mice Post Transplantation.

PBI-1402: A Low Molecular Weight Synthetic Hematopoietic Growth Stimulant.

PBI-1402: A New Candidate for the Treatment of Anemia.

PBI-1402: A Non-Toxic Immunorestorative Small Molecule for the Treatment of Anemia.

Email alerts

ASH Publications

American Society of Hematology

Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.

Oral Administration of PBI-1402 Significantly Reduces Erythropenia and Accelerates Peripheral Blood Recovery in Myeloablated Mice Post Transplantation.

PBI-1402: A Low Molecular Weight Synthetic Hematopoietic Growth Stimulant.

PBI-1402: A New Candidate for the Treatment of Anemia.

PBI-1402: A Non-Toxic Immunorestorative Small Molecule for the Treatment of Anemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only